Revenue
$23.09B
Fiscal year ended 2025-12-31Operating income
$5.87B
Fiscal year ended 2025-12-31Free cash flow
$4.38B
Fiscal year ended 2025-12-31AMPHENOL CORP /DE/ (APH) reported revenue of $23.09B and net income of $4.27B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from AMPHENOL CORP /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electronic Connectors.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.09B | $15.22B | $12.55B | $12.62B | $10.88B | $8.60B | $8.23B | $8.20B | $7.01B | $6.29B |
| Cost of revenue | $14.58B | $10.08B | $8.47B | $8.59B | $7.47B | $5.93B | $5.61B | $5.55B | $4.70B | $4.25B |
| Gross profit | $8.52B | $5.14B | $4.08B | $4.03B | $3.40B | $2.66B | $2.62B | $2.65B | $2.31B | $2.04B |
| Operating income | $5.87B | $3.16B | $2.56B | $2.59B | $2.11B | $1.64B | $1.62B | $1.69B | $1.43B | $1.21B |
| Net income | $4.27B | $2.42B | $1.93B | $1.90B | $1.59B | $1.20B | $1.16B | $1.20B | $650.50M | $822.90M |
| Research & development | $647.00M | $453.00M | $342.20M | $323.60M | $317.70M | $260.70M | $234.20M | $220.90M | $193.70M | $166.10M |
| Weighted-average diluted shares | shares 1.28B | shares 1.26B | shares 1.24B | shares 1.24B | shares 625.50M | shares 615.00M | shares 615.90M | shares 312.60M | shares 316.50M | shares 315.20M |
| Pretax income | $5.60B | $3.01B | $2.45B | $2.47B | $1.99B | $1.53B | $1.50B | $1.59B | $1.35B | $1.14B |
| Income tax expense | $1.30B | $570.30M | $509.30M | $550.60M | $409.10M | $313.30M | $331.90M | $371.50M | $691.70M | $308.50M |
| Diluted EPS | $3.34 | $1.92 | $1.55 | $1.53 | $2.54 | $1.96 | $1.88 | $3.85 | $2.06 | $2.61 |
| Selling, general & administrative | $2.55B | $1.86B | $1.49B | $1.42B | $1.23B | $1.01B | $971.40M | $959.50M | $878.30M | $798.20M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11.13B | $3.32B | $1.48B | $1.37B | $1.20B | $1.70B | $891.20M | $1.28B | $1.72B | $1.03B |
| Total assets | $36.24B | $21.44B | $16.53B | $15.33B | $14.68B | $12.33B | $10.82B | $10.04B | $10.00B | $8.50B |
| Current assets | $20.27B | $9.69B | $6.84B | $6.48B | $5.96B | $5.49B | $4.21B | $4.57B | $4.66B | $3.59B |
| Total liabilities | $22.73B | $11.58B | $8.10B | $8.23B | $8.30B | $6.88B | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $6.80B | $4.08B | $3.15B | $2.68B | $2.45B | $2.30B | $2.13B | $2.45B | $1.58B | $1.64B |
| Total equity incl. NCI | $13.50B | $9.85B | $8.40B | $7.07B | $6.36B | $5.45B | $4.60B | $4.06B | $4.04B | $3.72B |
| Temporary (mezzanine) equity | $9.30M | $8.70M | $30.70M | $20.60M | $19.00M | $0 | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $3.42B | $2.55B | $2.17B | $2.09B | $1.89B | $1.46B | $1.31B | $1.23B | $1.11B | $928.90M |
| Accounts receivable | $4.72B | $3.29B | $2.62B | $2.63B | $2.45B | $1.95B | $1.74B | $1.79B | $1.60B | $1.35B |
| Goodwill | $10.58B | $8.24B | $7.09B | $6.45B | $6.38B | $5.03B | $4.87B | $4.10B | $4.04B | $3.68B |
| Long-term debt | $14.56B | $6.48B | $3.98B | $4.58B | $4.80B | $3.64B | $3.20B | $2.81B | $3.54B | $2.64B |
| Accounts payable | $2.66B | $1.82B | $1.35B | $1.31B | $1.31B | $1.12B | $866.80M | $890.50M | $875.60M | $678.20M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.37B | $2.81B | $2.53B | $2.17B | $1.54B | $1.59B | $1.50B | $1.11B | $1.14B | $1.08B |
| Capital expenditures | $996.60M | $665.40M | $372.80M | $383.80M | $360.40M | $276.80M | $295.00M | $310.60M | $226.60M | $190.80M |
| Investing cash flow | -$5.08B | -$2.65B | -$1.39B | -$731.10M | -$1.89B | -$333.50M | -$1.23B | -$441.80M | -$380.20M | -$1.61B |
| Financing cash flow | $7.42B | $1.73B | -$1.01B | -$1.20B | -$145.20M | -$516.60M | -$648.40M | -$1.07B | -$140.10M | -$133.50M |
| Net change in cash | $7.81B | $1.84B | $101.90M | $176.00M | -$504.90M | $810.80M | -$388.10M | -$439.80M | $684.50M | -$702.60M |
| Stock-based compensation | $135.40M | $109.50M | $99.00M | $89.50M | $83.00M | $70.50M | $63.00M | $55.60M | $49.70M | $47.60M |
| Common dividends paid | $802.20M | $595.10M | $500.60M | $477.40M | $346.70M | $297.60M | $279.50M | $253.70M | $205.00M | $172.70M |
| Common share repurchases | $665.20M | $689.30M | $585.10M | $730.50M | $661.70M | $641.30M | $601.70M | $935.20M | $618.00M | $325.80M |
| Depreciation & amortization | $922.40M | $572.50M | $406.40M | $392.90M | $395.60M | $308.10M | $312.10M | $299.70M | $226.80M | $217.00M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $4.38B | $2.15B | $2.16B | $1.79B | $1.18B | $1.32B | $1.21B | $802.10M | $917.60M | $886.80M |
| Gross margin | 36.9% | 33.8% | 32.5% | 31.9% | 31.3% | 31.0% | 31.8% | 32.4% | 32.9% | 32.5% |
| Operating margin | 25.4% | 20.7% | 20.4% | 20.5% | 19.4% | 19.1% | 19.7% | 20.6% | 20.4% | 19.2% |
| FCF margin | 19.0% | 14.1% | 17.2% | 14.2% | 10.8% | 15.3% | 14.7% | 9.8% | 13.1% | 14.1% |
| SBC / revenue | 0.6% | 0.7% | 0.8% | 0.7% | 0.8% | 0.8% | 0.8% | 0.7% | 0.7% | 0.8% |
| Current ratio | 2.98x | 2.37x | 2.17x | 2.42x | 2.43x | 2.38x | 1.97x | 1.86x | 2.95x | 2.20x |
| Revenue YoY growth | 51.7% | 21.3% | -0.5% | 16.1% | 26.5% | 4.5% | 0.3% | 17.0% | 11.5% | Unavailable |
| Net margin | 18.5% | 15.9% | 15.4% | 15.1% | 14.6% | 14.0% | 14.0% | 14.7% | 9.3% | 13.1% |
| R&D / revenue | 2.8% | 3.0% | 2.7% | 2.6% | 2.9% | 3.0% | 2.8% | 2.7% | 2.8% | 2.6% |
| CapEx / revenue | 4.3% | 4.4% | 3.0% | 3.0% | 3.3% | 3.2% | 3.6% | 3.8% | 3.2% | 3.0% |
| Long-term debt / equity | 1.08x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 23.1% | 18.9% | 20.7% | 22.3% | 20.6% | 20.5% | 22.2% | 23.4% | 51.1% | 27.0% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open APH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-31View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-02-11View SEC filing
10-Q · Filed 2025-10-24View SEC filing
10-Q · Filed 2025-07-25View SEC filing
10-Q · Filed 2025-04-25View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.